acceleronpharma.com · 738
Merck is a global healthcare company that is dedicated to following the science to tackle some of the world's greatest health threats. With a focus on research, patients, and investors, Merck strives to improve lives through innovative treatments and technologies. Explore their stories, pipeline, and clinical trials to learn more about their impact on global health. Based in Rahway, N.J., USA, Merck is committed to transparency, sustainability, and diversity. Connect with them on social media to stay up to date on their latest developments.
acceleronpharma.com · years statistic
2004
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 2 |
| 7 | 0 |
| 8 | 1 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 1 |
2005
| 1 | 0 |
| 2 | 2 |
| 3 | 1 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 2 |
| 8 | 0 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2006
| 1 | 1 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 3 |
| 6 | 3 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 2 |
| 11 | 0 |
| 12 | 0 |
2007
| 1 | 3 |
| 2 | 1 |
| 3 | 0 |
| 4 | 2 |
| 5 | 1 |
| 6 | 2 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 2 |
| 11 | 0 |
| 12 | 1 |
2008
| 1 | 1 |
| 2 | 1 |
| 3 | 1 |
| 4 | 1 |
| 5 | 2 |
| 6 | 1 |
| 7 | 24 |
| 8 | 2 |
| 9 | 1 |
| 10 | 1 |
| 11 | 0 |
| 12 | 2 |
2009
| 1 | 1 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2010
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 1 |
| 5 | 1 |
| 6 | 1 |
| 7 | 0 |
| 8 | 3 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2011
| 1 | 0 |
| 2 | 2 |
| 3 | 1 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 1 |
| 9 | 4 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
2012
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 2 |
| 5 | 0 |
| 6 | 2 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 0 |
2013
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 1 |
| 5 | 1 |
| 6 | 4 |
| 7 | 1 |
| 8 | 1 |
| 9 | 3 |
| 10 | 0 |
| 11 | 0 |
| 12 | 1 |
2014
| 1 | 0 |
| 2 | 3 |
| 3 | 1 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 1 |
| 10 | 2 |
| 11 | 0 |
| 12 | 3 |
2015
| 1 | 1 |
| 2 | 5 |
| 3 | 3 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 2 |
| 8 | 2 |
| 9 | 1 |
| 10 | 2 |
| 11 | 1 |
| 12 | 1 |
2016
| 1 | 2 |
| 2 | 3 |
| 3 | 6 |
| 4 | 1 |
| 5 | 2 |
| 6 | 3 |
| 7 | 1 |
| 8 | 1 |
| 9 | 1 |
| 10 | 2 |
| 11 | 1 |
| 12 | 2 |
2017
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 1 |
| 5 | 6 |
| 6 | 5 |
| 7 | 3 |
| 8 | 6 |
| 9 | 3 |
| 10 | 4 |
| 11 | 2 |
| 12 | 4 |
2018
| 1 | 1 |
| 2 | 3 |
| 3 | 1 |
| 4 | 1 |
| 5 | 4 |
| 6 | 2 |
| 7 | 3 |
| 8 | 1 |
| 9 | 3 |
| 10 | 5 |
| 11 | 1 |
| 12 | 5 |
2019
| 1 | 1 |
| 2 | 2 |
| 3 | 0 |
| 4 | 6 |
| 5 | 2 |
| 6 | 4 |
| 7 | 3 |
| 8 | 4 |
| 9 | 17 |
| 10 | 2 |
| 11 | 15 |
| 12 | 15 |
2020
| 1 | 5 |
| 2 | 17 |
| 3 | 3 |
| 4 | 20 |
| 5 | 25 |
| 6 | 17 |
| 7 | 15 |
| 8 | 22 |
| 9 | 17 |
| 10 | 22 |
| 11 | 32 |
| 12 | 25 |
2021
| 1 | 15 |
| 2 | 0 |
| 3 | 3 |
| 4 | 5 |
| 5 | 10 |
| 6 | 14 |
| 7 | 4 |
| 8 | 5 |
| 9 | 10 |
| 10 | 16 |
| 11 | 21 |
| 12 | 12 |
2022
| 1 | 13 |
| 2 | 7 |
| 3 | 13 |
| 4 | 6 |
| 5 | 2 |
| 6 | 2 |
| 7 | 4 |
| 8 | 3 |
| 9 | 4 |
| 10 | 2 |
| 11 | 2 |
| 12 | 1 |
2023
| 1 | 4 |
| 2 | 3 |
| 3 | 5 |
| 4 | 7 |
| 5 | 3 |
| 6 | 4 |
| 7 | 2 |
| 8 | 3 |
| 9 | 3 |
| 10 | 1 |
| 11 | 1 |
| 12 | 0 |
2024
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 3 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
